General Catalyst Group Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Hold
4,884,193
1.22% 7
2025
Q4
$10.7M Hold
4,884,193
4.85% 6
2025
Q3
$7.77M Hold
4,884,193
0.26% 8
2025
Q2
$7.91M Buy
+4,884,193
New +$7.89M 0.18% 8

Other funds holding GUTS

General Catalyst Group Management's GUTS Position: Q1 2026 in Review

General Catalyst Group Management held its Fractyl Health (GUTS) position steady in Q1 2026 at 4,884,193 shares worth $2.24M. The position accounts for 1.22% of the portfolio, ranked #7.

General Catalyst Group Management first reported a position in GUTS in Q2 2025 and has held it in 4 quarters since. The position peaked at $10.7M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • General Catalyst Group Management held 4,884,193 shares of Fractyl Health worth $2.24M as of Q1 2026.
  • General Catalyst Group Management left its Fractyl Health share count unchanged in Q1 2026.
  • Fractyl Health made up 1.22% of General Catalyst Group Management's portfolio in Q1 2026, its #7 holding.
  • General Catalyst Group Management first reported a position in Fractyl Health in Q2 2025 and has held it in 4 quarters since.
  • General Catalyst Group Management's Fractyl Health position peaked at $10.7M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on General Catalyst Group Management's 13F filing for Q1 2026, filed 15 May 2026.